The CD8 count also demonstrated a positive trend, rising from 331/mm 3 to 651/mm 3 over the same timeframe.
← all excerpts
Real-World Experience with Long-Acting Injectable Cabotegravir/Rilpivirine in HIV Patients with Unsuppressed Viral Load.
1
—
—
The CD8 count also demonstrated a positive trend, rising from 331/mm 3 to 651/mm 3 over the same timeframe.